CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 58.31% | -0.16% | — | |
| 2 | VCYT | Veracyte INC | Stock-Other | 20.03% | — | -33.33% | |
| 3 | 2JQ | Gritstone Bio INC | Stock-Other | 10.07% | — | — | |
| 4 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 6.11% | — | -31.03% | |
| 5 | OCUL | Ocular Therapeutix INC | Stock-Other | 2.84% | — | — | |
| 6 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 1.13% | — | -49.87% | |
| 7 | ✓ | Second Sight Med Prods INC | Stock-Other | 1.05% | — | — | |
| 8 | CLVSEUR | Clovis Oncology INC | Stock-Other | 0.44% | — | — | |
| 9 | ✓ | Opgen, Inc. | Stock-Other | 0.01% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | +8.3% | — | Unchanged |
| 2 | ✓ | Opgen, Inc. | 0% | — | Unchanged |
| 3 | OCUL | Ocular Therapeutix INC | -0.1% | — | Unchanged |
| 4 | ✓ | Second Sight Med Prods INC | -0.1% | — | Unchanged |
| 5 | CLVSEUR | Clovis Oncology INC | -0.4% | — | Unchanged |
| 6 | CBAYUSD | Cymabay Therapeutics INC | -3.6% | -49.87% | Trim |
| 7 | BOLDEUR | Audentes Therapeutics INC | -4.2% | -31.03% | Trim |
| 8 | VCYT | Veracyte INC | -9.8% | -33.33% | Trim |
| 9 | 2JQ | Gritstone Bio INC | — | NEW | New buy |
| 10 | AKAOQ | Achaogen INC | — | EXIT | Sold out |